Ticker LaunchIPO
Generation Bio Co.
Formerly Generation Bio Co.
Generation Bio Co. priced its initial public offering on Jun 12, 2020 at $19.00 per share, within its $18.00–$19.00 range, raising $200M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $848.1M. WilmerHale advised the company and Davis Polk advised the underwriters.
- Status
- IPO
- Exchange
- Nasdaq Global Select
- Priced
- Jun 12, 2020
- IPO price
- $19.00
- Price range
- $18.00–$19.00
- Raised
- $200M
- Market cap at IPO price
- $848.1M
- First filed
- May 22, 2020
- Company counsel
- WilmerHale
- Underwriters' counsel
- Davis Polk
- Sector
- Biotech & pharma
- Country / state
- MA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed May 22, 2020
- Latest amendment Jun 11, 2020
- Final prospectus (424B4) Jun 12, 2020
- All filings on EDGAR CIK 1733294
Other Biotech & pharma IPOs in 2020
- Royalty Pharma plcRPRX · Jun 17, 2020 · $2.18B
- Vaxcyte, Inc.PCVX · Jun 15, 2020 · $250M
- Avidity Biosciences, Inc.RNA · Jun 12, 2020 · $259.2M
- Lantern Pharma Inc.LTRN · Jun 12, 2020 · $26.2M
- Calliditas Therapeutics ABCALTX · Jun 8, 2020
- Legend Biotech CorpLEGN · Jun 8, 2020 · $423.8M